We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this site, you agree to our cookie policy. Privacy Policy
Enter a target name, and the platform automatically gathers public information, integrates structure–function relationships and disease mechanisms, assesses druggability and the competitive landscape, and drafts a standardized report. The result is an editable target assessment report for project discussion.
Report Coverage
Why Is This Needed?
"Early-stage target assessment often spans genes, structures, epitopes, competitors, patents, and market data. Manual integration can take weeks and may still miss key information. Automating public information gathering and structured report drafting helps teams understand a target's opportunities and risks before project selection."
Key Advantages
Target assessment spans many public databases, and manual cross-database retrieval and integration often take weeks.
Relying on individual experience makes it easy to overlook key dimensions such as druggability, epitopes, competitors, and patents.
Without charts and structured conclusions, teams may struggle to quickly identify the key points during project discussions.
Enter a target name, and the platform automatically aggregates and integrates public information from multiple sources.
A standardized report framework systematically covers biology, druggability, epitopes, competition, and IP.
The platform automatically generates charts such as assessment cards, opportunity–risk matrices, and epitope scorecards to support project discussion.
Coverage
The target assessment report is organized into six sections, covering the path from target profiling to project-selection decisions.
Basic information, database identifiers, expression profiles, biological functions, and disease mechanisms that outline the overall target profile.
Indication assessment, epidemiology, standard of care, unmet needs, and market size to support indication prioritization.
Species homology, structure–function relationships, epitope analysis, and epitope accessibility to inform antibody design.
Modality suitability, benchmark antibody analysis, and wet-lab screening feasibility to evaluate potential development paths.
Pipeline and competitive landscape analysis, patent and literature trends, and recent deals to assess competitive intensity and opportunities for differentiation.
Differentiation strategy, AI-design SWOT analysis, epitope prioritization, risk register, overall scoring, and an action plan for project-level recommendations.
Pipeline
Enter a target name to gather and analyze public information and generate a structured assessment report with supporting charts.
After you confirm the outline, the platform gathers and analyzes public information. The resulting report is editable and exportable, with sources and evidence levels annotated.
Use Cases
Best suited for projects that need a fast, systematic assessment of a target's biology, druggability, and competitive landscape before project selection.
Start with a target or gene name; a UniProt ID helps identify the intended protein. Reports cover the target profile, indications and market, structure and epitopes, druggability, competition and IP, and decision recommendations, with sources and items requiring verification.
Usually, you only need to provide a target name or gene name to get started. Providing a UniProt ID can make the results more precise.
It covers six sections: target profile, indication and market, structure and epitope, druggability, competition and IP, and recommendations and next steps. Together, they form a complete report framework from executive summary to references.
The research is based on public databases and literature, with evidence levels and sources annotated. Information that cannot be verified is marked as pending verification rather than fabricated.
The report organizes evidence and assessment scores to support project discussions. Teams should make final decisions using their own judgment and internal data.
Enter a target name to quickly generate a target assessment report covering biology, druggability, competitive landscape, and epitope analysis.